Methotrexate Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 03/13/2023.
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9830-01
- Dosage Form
- Injection
- Presentation
- Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)
- Initial Posting
- 03/13/2023
- Revised Date